International Journal of Rheumatic Diseases
Scope & Guideline
Advancing understanding in rheumatology.
Introduction
Aims and Scopes
- Clinical Research in Rheumatic Diseases:
The journal publishes original research focused on the clinical aspects of rheumatic diseases, including treatment outcomes, patient management strategies, and the evaluation of therapeutic interventions. - Experimental and Translational Research:
Research that explores the underlying mechanisms of rheumatic diseases, including genetic, immunological, and environmental factors, is a key focus area, aiming to translate findings into clinical practice. - Epidemiological Studies:
The journal includes studies that examine the prevalence, incidence, and risk factors associated with rheumatic diseases, contributing to a better understanding of these conditions in different populations. - Innovative Therapeutic Approaches:
Research on new pharmacological treatments, including biologics and targeted therapies, as well as traditional and complementary medicine approaches, is highlighted. - Patient-Centered Care:
The journal emphasizes research that improves patient quality of life, including studies on psychosocial aspects, healthcare utilization, and patient education. - Multidisciplinary Approaches:
The journal encourages interdisciplinary research that involves collaboration among rheumatologists, immunologists, physiotherapists, and other healthcare professionals to optimize patient outcomes.
Trending and Emerging
- Impact of COVID-19 on Rheumatic Diseases:
A significant number of studies are focusing on the effects of COVID-19 on patients with rheumatic diseases, including vaccine responses, disease flares, and management strategies during the pandemic. - Biologics and Targeted Therapies:
There is an increasing emphasis on research related to the efficacy, safety, and long-term outcomes of biologic therapies and JAK inhibitors, reflecting the ongoing evolution of treatment paradigms in rheumatology. - Microbiome and Autoimmunity:
Emerging research is exploring the relationship between gut microbiota and autoimmune diseases, suggesting potential therapeutic targets and new insights into disease pathogenesis. - Personalized Medicine in Rheumatology:
Studies focusing on personalized approaches to treatment based on genetic, environmental, and clinical factors are becoming more prevalent, emphasizing the need for tailored therapies. - Patient-Reported Outcomes and Quality of Life:
There is a growing focus on understanding patient-reported outcomes and quality of life measures, reflecting an increasing recognition of the importance of patient-centered care in rheumatology. - Multimorbidity and Comorbid Conditions:
Research exploring the intersection of rheumatic diseases with other chronic conditions, such as cardiovascular disease and diabetes, is gaining importance as it impacts treatment strategies and patient management.
Declining or Waning
- Traditional Therapeutic Approaches:
Research on conventional treatments, such as non-steroidal anti-inflammatory drugs (NSAIDs) and older disease-modifying anti-rheumatic drugs (DMARDs), has seen a decrease, likely overshadowed by the rapid development of biologics and JAK inhibitors. - Basic Science without Clinical Application:
Studies focused purely on basic science findings, without clear pathways to clinical application or relevance to patient care, seem to be less frequently published, indicating a shift towards more translational research. - Single-Center Studies:
The prevalence of single-center studies is declining, as there is a growing emphasis on multicenter, larger scale studies that offer broader insights and greater generalizability to findings. - Descriptive Epidemiological Studies:
While epidemiological research remains important, there appears to be a decline in purely descriptive studies that do not incorporate advanced analytical methods or novel insights into disease mechanisms.
Similar Journals
ZEITSCHRIFT FUR RHEUMATOLOGIE
Connecting researchers and clinicians for better rheumatic disease outcomes.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.
Current Treatment Options in Rheumatology
Advancing rheumatology through innovative treatment insights.Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.
Reumatologia Clinica
Empowering insights into rheumatic diseases.Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Connecting Clinical Excellence with Research RigorJCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.
Current Rheumatology Reviews
Exploring breakthroughs in rheumatology advancements.Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.
BMC Rheumatology
Advancing knowledge in rheumatology without barriers.BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.
Revista Cubana de Reumatologia
Empowering global collaboration in rheumatology.Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.
Reumatismo
Pioneering research in rheumatic diseases, accessible to all.Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.
Acta Reumatologica Portuguesa
Transforming clinical practices with cutting-edge findings.Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.
AKTUELLE RHEUMATOLOGIE
Connecting researchers to advance the field of rheumatology.AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.